Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis Vaccines
Researchers detail new studies and findings in the area of tuberculosis vaccines
September 14th, 2005
Tuberculosis vaccines data are the focus of recent research from New Zealand and Kingdom of Saudi Arabia. Study 1: The order of prime-boost vaccination of neonatal calves with Mycobacterium bovis BCG and a DNA vaccine encoding mycobacterial proteins Hsp65, Hsp70, and Apa is not critical for enhancing protection against bovine tuberculosis. According to recent research from New Zealand and England, "Priming neonatal calves at birth with a Mycobacterium bovis bacillus Calmette-Guerin (BCG) vaccine and boosting with a DNA vaccine consisting of plasmids encoding mycobacterial antigens Hsp65, Hsp70, and Apa or the reverse prime-boost...
Source: Vaccine Weekly (2005-09-14)
|
